Telesis Bio Secures Financing of 28.0 Million
| TBIODelisted Stock | USD 2.98 0.02 0.67% |
About 55% of Telesis Bio's investors are presently thinking to get in. The analysis of overall sentiment of trading Telesis Bio pink sheet suggests that some investors are interested at this time. Telesis Bio's investing sentiment overview a quick insight into current market opportunities from investing in Telesis Bio. Many technical investors use Telesis Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Telesis |
Up to an Additional 46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN DIEGO, May 31, 2023 Telesis Bio Inc. , a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced it has signed a securities purchase agreement with a syndicate of healthcare-focused institutional investors tha
Read at finance.yahoo.com
 |
Telesis Bio Fundamental Analysis
We analyze Telesis Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Telesis Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Telesis Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Telesis Bio is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Telesis Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Telesis Bio pink sheet to make a market-neutral strategy. Peer analysis of Telesis Bio could also be used in its relative valuation, which is a method of valuing Telesis Bio by comparing valuation metrics with similar companies.
Peers
Telesis Bio Related Equities
| HURC | Hurco Companies | 0.62 | ||||
| EMR | Emerson Electric | 0.22 | ||||
| EME | EMCOR | 0.15 | ||||
| PH | Parker Hannifin | 0.56 | ||||
| CHX | ChampionX | 1.35 | ||||
| TSN | Tyson Foods | 1.92 | ||||
| HIHO | Highway Holdings | 2.55 | ||||
| EVVTY | Evolution Gaming | 3.47 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |